Marginal Zone Lymphoma
Showing NaN - NaN of 8
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,
Terminated
- Diffuse Large B Cell Lymphoma
- +3 more
- Acalabrutinib
- +4 more
-
Miami, FloridaUniversity of Miami
Aug 23, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
Marginal Zone Lymphoma Trial in Miami (Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg)
Recruiting
- Marginal Zone Lymphoma
- Loncastuximab tesirine 150 µg/Kg
- Loncastuximab tesirine 75µg/Kg
-
Miami, FloridaUniversity of Miami
Jul 12, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,
Active, not recruiting
- Follicular Lymphoma
- +3 more
- Vitamin D
- +2 more
-
Miami, Florida
- +6 more
Mar 6, 2022
Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Miami (Rituximab, Bortezomib, Cyclophosphamide)
Terminated
- Lymphoma
- +2 more
- Rituximab
- +3 more
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center - Miam
Nov 6, 2017
Marginal Zone Lymphoma Trial in Miami (Rituximab, Ibritumomab Tiuxetan)
Completed
- Marginal Zone Lymphoma
- Rituximab
- Ibritumomab Tiuxetan
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center - Miam
Nov 30, 2015